SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare’s arm gets UK MHRA approval for Imatinib oral solution

07 Apr 2020 Evaluate

Shilpa Medicare through its UK subsidiary Koanaa Healthcare, has received UK MHRA approval for Imatinib oral solution. The approval of Imatinib Oral Solution represents a major step forward in treatment options for cancers in pediatric and geriatric patients, patients with swallowing difficulties and also offers dose titration across the patient population.

Imatinib Oral Solution, a first of its kind in the world, is the only approved product which facilitates accurate dose titrations and avoids unnecessary overdosing due to fixed doses, 100 mg and 400 mg, in the presently available marketed tablets. Imatinib Oral Solution is available as 80mg/mL. Imatinib Oral Solution is expected to be available in the UK in the second quarter of 2020 will be supplied from a UK based state of the art manufacturing facility LM pharmaceuticals. Imatinib Oral Solution is an innovative product and is expected to have patent protection until 2038.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

411.55 0.30 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×